Sovran Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2051471 SAN DIEGO, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$321,746

-$4,328,774 QoQ

Shares Held

516

-91.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#927

of 1,329 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sovran Advisors, LLC holds $9,234,344 across 5 Biotechnology names. REGN ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	84,984	$6,738,381
2	GALT	Galectin Therapeutics Inc	257,997	$1,197,106
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,479	$734,663
4	REGN	Regeneron Pharmaceuticals, Inc. This page	516	$321,746
5	ASND	Ascendis Pharma A/S	909	$242,448

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,746	516	-91.4%	Shares	Sole	2026-07-30
2026-03-31	$4,650,520	6,019	-30.2%	Shares	Sole	2026-05-01
2025-12-31	$6,652,747	8,619	-22.6%	Shares	Sole	2026-01-20
2025-09-30	$6,262,563	11,138	+121.9%	Shares	Sole	2025-10-31
2025-06-30	$2,635,500	5,020	—	Shares	Sole	2025-07-10
No filing history on record for this holder in this stock.